Statistics for Quest Diagnostics (id:8766 DGX)
Valuation metrics
Market cap
17.92B
Enterprise value
24.37B
Trailing P/E (ttm)
21.58
Forward P/E
16.45
PEG ratio
16.45
Price/Sales (ttm)
1.88
Price/Book (mrq)
2.64
Enterprise Value/Revenue
2.55
Enterprise Value/EBITDA
13.50
Overview
Shares outstanding
111.62M
Float
110.69M
Shares short
2.38M
% Held by insiders
0.00%
% Held by institutions
0.90%
Average volume (10 days)
825.72K
Average volume (90 days)
Price summary
52-Week low
123.04
52-Week high
162.88
52-Week change
15.98%
Beta
0.89
50-Day moving average
153.69
200-Day moving average
141.43
Dividends and splits
Forward annual dividend rate
3.00
Forward annual dividend yield
0.02
Trailing annual dividend rate
2.96%
Trailing annual dividend yield
0.02
5-Year annual dividend yield
1.90
Payout ratio
0.40
Dividend date
October 21th, 2024
Ex-dividend date
October 04th, 2024
Last split factor
2:1
Last split date
June 21th, 2005
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
8.82%
Operating margin
14.19%
Operational effectiveness
Return on assets
5.66%
Return on equity
13.22%
Income statement
Revenue (ttm)
85.74
Revenue per share (ttm)
85.74
Quarterly revenue growth (yoy)
0.00
Gross profit (ttm)
3.05B
EBITDA
1.78B
Net income to common (ttm)
838.00M
Diluted EPS (ttm)
7.44
Quarterly earnings growth (yoy)
0.40%
Balance sheet
Total cash (mrq)
764.00M
Total cash per share (mrq)
6.84
Total debt (mrq)
6.97B
Total Debt/Equity (mrq)
100.71
Current ratio (mrq)
125.40%
Book value per share (mrq)
60.80
Cash flow
Cash flow statement
1.40B
Levered free cash flow (LFCF)
853.25M